Drug Interactions
Is cannabis safe with blood thinners like warfarin?
Research summary prepared with AI assistance · Not authored by Ken Feldman or Nadine Laham · For general information only
~7 minute read
The short answer
The interaction between cannabis and warfarin is well-documented and clinically meaningful: cannabis can raise warfarin levels, increasing bleeding risk. The picture for newer blood thinners (apixaban, rivaroxaban, dabigatran) is less studied but theoretical interactions exist. If you take any blood thinner, this is one of the most important conversations to have with your prescribing doctor before using cannabis.
Why this interaction matters more than most
Most cannabis-medication interactions produce subtle effects that build up gradually. The cannabis-warfarin interaction is different. It can shift your INR — the blood test that measures how thin your blood is — into a dangerous range fast. Several published case reports describe older adults whose INRs more than doubled within days of starting regular cannabis use, in one case leading to hospitalization for bleeding.
For an older adult on warfarin, the consequences of bleeding are not abstract. Falls become more dangerous. A minor bump on the head becomes a reason to go to the emergency room. Bruising and nosebleeds become daily events.
The mechanism
Warfarin is metabolized in the liver primarily by two enzymes: CYP2C9 and CYP3A4. Cannabis (specifically the cannabinoids THC and CBD) inhibits both of these enzymes. When the enzymes that clear warfarin are slowed down, warfarin accumulates in the bloodstream. The result: more anticoagulation than the prescribed dose was meant to produce.
CBD is the more potent inhibitor of the two. This is one of the few cases where high-CBD products are riskier than high-THC products for an interaction.
Worth knowing: The interaction is dose-dependent and chronic-use-dependent. Occasional, low-dose cannabis use is less likely to produce a significant shift than daily use, but the threshold varies considerably between individuals. There is no "safe" cannabis dose with warfarin that has been established in research.
What about the newer blood thinners?
The Direct Oral Anticoagulants (DOACs) — apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa) — are increasingly common alternatives to warfarin. They don’t require regular blood monitoring, which is part of why they’re prescribed.
The interaction picture with cannabis is murkier for these drugs:
- Apixaban and rivaroxaban are also metabolized by CYP3A4. Theoretical interactions with cannabis exist, but published case reports are sparse compared to warfarin.
- Dabigatran uses a different pathway and is less likely to interact with cannabis pharmacokinetically.
- Aspirin and clopidogrel (Plavix) are antiplatelet drugs, not anticoagulants. Cannabis itself has mild antiplatelet effects, so combining them produces an additive bleeding risk through a different mechanism.
The honest summary for the DOACs: less data, more uncertainty, but enough biological plausibility to warrant the same conversation with your doctor that you’d have about warfarin.
Signs to watch for
If you do use cannabis while on a blood thinner — ideally only after a conversation with your prescribing doctor — these are signs that bleeding risk has increased and that you should call your doctor right away:
- Bruising that appears without a clear cause, or that’s larger than usual
- Nosebleeds that are new or more frequent
- Bleeding gums when you brush your teeth
- Blood in urine or stool, or stool that looks black and tarry
- Cuts that take much longer than usual to stop bleeding
- An unusual headache, particularly after any bump to the head
What the evidence says
The cannabis-warfarin interaction is supported by case reports, pharmacokinetic studies, and known enzyme inhibition mechanisms. This places it firmly in Medically Documented territory — not a hypothetical concern, but a measured one. The size of the effect varies between individuals, but the existence of the effect does not.
For the DOACs, the evidence is currently Theoretical / Emerging. Mechanism is plausible; clinical case reports are limited. Absence of evidence is not evidence of absence, and the consequences of being wrong are serious.
Discuss with your doctor
- Whether your current INR (if on warfarin) leaves any room for an upward shift
- How often you would need INR monitoring after starting cannabis use
- Your underlying reason for being on a blood thinner (atrial fibrillation, mechanical heart valve, history of clot)
- Whether switching to a different anticoagulant might be appropriate if you intend to use cannabis regularly
- What signs of bleeding warrant an immediate call versus an emergency room visit